Logo image of INVX

INNOVEX INTERNATIONAL INC (INVX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:INVX - US4576511079 - Common Stock

24.31 USD
+0.03 (+0.12%)
Last: 1/15/2026, 8:04:00 PM
24.31 USD
0 (0%)
After Hours: 1/15/2026, 8:04:00 PM
Fundamental Rating

7

Taking everything into account, INVX scores 7 out of 10 in our fundamental rating. INVX was compared to 62 industry peers in the Energy Equipment & Services industry. INVX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. INVX is growing strongly while it is still valued neutral. This is a good combination! With these ratings, INVX could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • INVX had positive earnings in the past year.
  • INVX had a positive operating cash flow in the past year.
  • In multiple years INVX reported negative net income over the last 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: INVX reported negative operating cash flow in multiple years.
INVX Yearly Net Income VS EBIT VS OCF VS FCFINVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • The Return On Assets of INVX (8.06%) is better than 87.10% of its industry peers.
  • With a decent Return On Equity value of 9.73%, INVX is doing good in the industry, outperforming 69.35% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 8.34%, INVX is doing good in the industry, outperforming 69.35% of the companies in the same industry.
Industry RankSector Rank
ROA 8.06%
ROE 9.73%
ROIC 8.34%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
INVX Yearly ROA, ROE, ROICINVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • With an excellent Profit Margin value of 10.58%, INVX belongs to the best of the industry, outperforming 87.10% of the companies in the same industry.
  • INVX's Profit Margin has improved in the last couple of years.
  • INVX's Operating Margin of 12.21% is fine compared to the rest of the industry. INVX outperforms 67.74% of its industry peers.
  • INVX's Operating Margin has improved in the last couple of years.
  • With a decent Gross Margin value of 32.35%, INVX is doing good in the industry, outperforming 72.58% of the companies in the same industry.
  • In the last couple of years the Gross Margin of INVX has grown nicely.
Industry RankSector Rank
OM 12.21%
PM (TTM) 10.58%
GM 32.35%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
INVX Yearly Profit, Operating, Gross MarginsINVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

8

2. Health

2.1 Basic Checks

  • INVX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for INVX has been increased compared to 1 year ago.
  • The number of shares outstanding for INVX has been increased compared to 5 years ago.
  • Compared to 1 year ago, INVX has a worse debt to assets ratio.
INVX Yearly Shares OutstandingINVX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
INVX Yearly Total Debt VS Total AssetsINVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

  • An Altman-Z score of 6.58 indicates that INVX is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 6.58, INVX belongs to the top of the industry, outperforming 98.39% of the companies in the same industry.
  • INVX has a debt to FCF ratio of 0.19. This is a very positive value and a sign of high solvency as it would only need 0.19 years to pay back of all of its debts.
  • INVX's Debt to FCF ratio of 0.19 is amongst the best of the industry. INVX outperforms 93.55% of its industry peers.
  • A Debt/Equity ratio of 0.02 indicates that INVX is not too dependend on debt financing.
  • INVX has a Debt to Equity ratio of 0.02. This is amongst the best in the industry. INVX outperforms 88.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.19
Altman-Z 6.58
ROIC/WACC0.95
WACC8.79%
INVX Yearly LT Debt VS Equity VS FCFINVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

  • INVX has a Current Ratio of 4.78. This indicates that INVX is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of INVX (4.78) is better than 95.16% of its industry peers.
  • A Quick Ratio of 2.93 indicates that INVX has no problem at all paying its short term obligations.
  • The Quick ratio of INVX (2.93) is better than 91.94% of its industry peers.
Industry RankSector Rank
Current Ratio 4.78
Quick Ratio 2.93
INVX Yearly Current Assets VS Current LiabilitesINVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

9

3. Growth

3.1 Past

  • INVX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 246.15%, which is quite impressive.
  • The Earnings Per Share has been growing by 123.23% on average over the past years. This is a very strong growth
  • INVX shows a strong growth in Revenue. In the last year, the Revenue has grown by 47.71%.
  • The Revenue has been growing by 9.76% on average over the past years. This is quite good.
EPS 1Y (TTM)246.15%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%170.59%
Revenue 1Y (TTM)47.71%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%58.09%

3.2 Future

  • Based on estimates for the next years, INVX will show a very strong growth in Earnings Per Share. The EPS will grow by 66.90% on average per year.
  • Based on estimates for the next years, INVX will show a very strong growth in Revenue. The Revenue will grow by 22.31% on average per year.
EPS Next Y446.5%
EPS Next 2Y160.71%
EPS Next 3Y95.77%
EPS Next 5Y66.9%
Revenue Next Year94.87%
Revenue Next 2Y42.23%
Revenue Next 3Y28.85%
Revenue Next 5Y22.31%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
INVX Yearly Revenue VS EstimatesINVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
INVX Yearly EPS VS EstimatesINVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4

6

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 25.59 indicates a quite expensive valuation of INVX.
  • INVX's Price/Earnings ratio is in line with the industry average.
  • INVX's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.54.
  • With a Price/Forward Earnings ratio of 14.91, INVX is valued correctly.
  • INVX's Price/Forward Earnings ratio is rather cheap when compared to the industry. INVX is cheaper than 80.65% of the companies in the same industry.
  • INVX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.31.
Industry RankSector Rank
PE 25.59
Fwd PE 14.91
INVX Price Earnings VS Forward Price EarningsINVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • INVX's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. INVX is more expensive than 62.90% of the companies in the same industry.
  • INVX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. INVX is cheaper than 79.03% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.87
EV/EBITDA 8.83
INVX Per share dataINVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of INVX may justify a higher PE ratio.
  • INVX's earnings are expected to grow with 95.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.06
PEG (5Y)0.21
EPS Next 2Y160.71%
EPS Next 3Y95.77%

0

5. Dividend

5.1 Amount

  • INVX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

INNOVEX INTERNATIONAL INC

NYSE:INVX (1/15/2026, 8:04:00 PM)

After market: 24.31 0 (0%)

24.31

+0.03 (+0.12%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)11-03
Earnings (Next)N/A
Inst Owners47.97%
Inst Owner Change1.48%
Ins Owners1.52%
Ins Owner Change-2.28%
Market Cap1.68B
Revenue(TTM)955.34M
Net Income(TTM)101.12M
Analysts77.78
Price Target25.5 (4.9%)
Short Float %N/A
Short Ratio8.36
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend1.45
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-43.31%
Min EPS beat(2)-62.53%
Max EPS beat(2)-24.08%
EPS beat(4)1
Avg EPS beat(4)-15.03%
Min EPS beat(4)-62.53%
Max EPS beat(4)49.19%
EPS beat(8)1
Avg EPS beat(8)-142.72%
EPS beat(12)2
Avg EPS beat(12)-111.91%
EPS beat(16)3
Avg EPS beat(16)-84.71%
Revenue beat(2)1
Avg Revenue beat(2)2.01%
Min Revenue beat(2)-4.42%
Max Revenue beat(2)8.43%
Revenue beat(4)3
Avg Revenue beat(4)5.34%
Min Revenue beat(4)-4.42%
Max Revenue beat(4)10.21%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)10.29%
PT rev (3m)36.36%
EPS NQ rev (1m)0%
EPS NQ rev (3m)10.47%
EPS NY rev (1m)0%
EPS NY rev (3m)-11.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.61%
Valuation
Industry RankSector Rank
PE 25.59
Fwd PE 14.91
P/S 1.75
P/FCF 11.87
P/OCF 9.57
P/B 1.61
P/tB 2.04
EV/EBITDA 8.83
EPS(TTM)0.95
EY3.91%
EPS(NY)1.63
Fwd EY6.71%
FCF(TTM)2.05
FCFY8.43%
OCF(TTM)2.54
OCFY10.44%
SpS13.86
BVpS15.07
TBVpS11.94
PEG (NY)0.06
PEG (5Y)0.21
Graham Number17.95
Profitability
Industry RankSector Rank
ROA 8.06%
ROE 9.73%
ROCE 10.56%
ROIC 8.34%
ROICexc 9.79%
ROICexgc 12.7%
OM 12.21%
PM (TTM) 10.58%
GM 32.35%
FCFM 14.78%
ROA(3y)3.87%
ROA(5y)-0.76%
ROE(3y)4.84%
ROE(5y)-0.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y74.94%
ROICexc growth 3YN/A
ROICexc growth 5Y70.29%
OM growth 3YN/A
OM growth 5Y64.81%
PM growth 3YN/A
PM growth 5Y120.24%
GM growth 3Y12.33%
GM growth 5Y4.04%
F-Score7
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.19
Debt/EBITDA 0.12
Cap/Depr 59.02%
Cap/Sales 3.54%
Interest Coverage 80.3
Cash Conversion 100.59%
Profit Quality 139.63%
Current Ratio 4.78
Quick Ratio 2.93
Altman-Z 6.58
F-Score7
WACC8.79%
ROIC/WACC0.95
Cap/Depr(3y)71.76%
Cap/Depr(5y)56.98%
Cap/Sales(3y)4.99%
Cap/Sales(5y)4.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)246.15%
EPS 3YN/A
EPS 5Y123.23%
EPS Q2Q%170.59%
EPS Next Y446.5%
EPS Next 2Y160.71%
EPS Next 3Y95.77%
EPS Next 5Y66.9%
Revenue 1Y (TTM)47.71%
Revenue growth 3Y27.02%
Revenue growth 5Y9.76%
Sales Q2Q%58.09%
Revenue Next Year94.87%
Revenue Next 2Y42.23%
Revenue Next 3Y28.85%
Revenue Next 5Y22.31%
EBIT growth 1Y95.65%
EBIT growth 3YN/A
EBIT growth 5Y80.9%
EBIT Next Year100.38%
EBIT Next 3Y37.48%
EBIT Next 5Y29.59%
FCF growth 1Y326.98%
FCF growth 3Y41.07%
FCF growth 5Y90.29%
OCF growth 1Y586.06%
OCF growth 3Y34.47%
OCF growth 5Y44.76%

INNOVEX INTERNATIONAL INC / INVX FAQ

Can you provide the ChartMill fundamental rating for INNOVEX INTERNATIONAL INC?

ChartMill assigns a fundamental rating of 7 / 10 to INVX.


Can you provide the valuation status for INNOVEX INTERNATIONAL INC?

ChartMill assigns a valuation rating of 6 / 10 to INNOVEX INTERNATIONAL INC (INVX). This can be considered as Fairly Valued.


What is the profitability of INVX stock?

INNOVEX INTERNATIONAL INC (INVX) has a profitability rating of 6 / 10.


How financially healthy is INNOVEX INTERNATIONAL INC?

The financial health rating of INNOVEX INTERNATIONAL INC (INVX) is 8 / 10.


Can you provide the dividend sustainability for INVX stock?

The dividend rating of INNOVEX INTERNATIONAL INC (INVX) is 0 / 10 and the dividend payout ratio is 0%.